Pharmacogenomic Testing: Delivering Precision Medicine

By reducing adverse drug responses, improving efficacy, and ensuring each patient gets the drug they are most likely to respond to, pharmacogenomics testing helps deliver the promise of precision medicine. In order to help empower the personalization of cancer treatment, we offer pharmacogenomic testing for doctors, hospitals, and cancer centers, as well as for biopharma and biotech companies engaged in oncology-focused clinical trials.

Below is a sample of the pharmacogenomic genotyping assays we offer for immunology and hematology. In addition to conventional pharmacogenomics tests, we are experienced in providing custom assay development and validation.

ABCC2
ADRA2B
ATM
ATR
CCR5
CD86
CRHR1
CTLA4
CYP2B6
CYP2C19
CYP2C9
CYP3A4
CYP3A5
Factor V F5
Factor XIII FXIII
Fibrinogen
HLA-A
HLA-B
IL28B
IL4RA
ITIH2
ITPA
PON1
Prothrombin
VKORC1